Q3 2024 |
12 |
$439M |
+$34.9M |
-$27.1M |
+$7.82M |
CZR, AVAH, BRSP, CSTM, XPOF
|
13F-HR |
11/14/2024, 04:00 PM |
Q2 2024 |
14 |
$388M |
+$65.8M |
-$9.32M |
+$56.5M |
CZR, CSTM, BRSP, XPOF, AVAH
|
13F-HR |
8/14/2024, 04:17 PM |
Q1 2024 |
1 |
$79.6M |
$0 |
$0 |
|
CSTM
|
New Holdings |
5/16/2024, 11:10 AM |
Q1 2024 |
11 |
$361M |
+$99.6M |
-$48.8M |
+$50.8M |
CZR, CSTM, BRSP, AVAH, CNK
|
13F-HR |
5/15/2024, 04:09 PM |
Q4 2023 |
11 |
$308M |
+$41.6M |
-$43.2M |
-$1.6M |
BRSP, CSTM, THC, AVAH, CZR
|
13F-HR |
2/14/2024, 04:49 PM |
Q3 2023 |
8 |
$268M |
+$1.8M |
-$17.2M |
-$15.4M |
BRSP, CSTM, CZR, THC, AVAH
|
13F-HR |
11/14/2023, 04:47 PM |
Q2 2023 |
8 |
$308M |
+$5.69M |
-$67M |
-$61.3M |
BRSP, THC, CSTM, CZR, AVAH
|
13F-HR |
8/14/2023, 04:41 PM |
Q1 2023 |
10 |
$324M |
+$113M |
$0 |
+$113M |
THC, BRSP, CSTM, CZR, SAFE
|
13F-HR |
5/15/2023, 04:43 PM |
Q4 2022 |
6 |
$186M |
$0 |
-$148M |
-$148M |
BRSP, THC, CSTM, CZR, AVAH
|
13F-HR |
2/14/2023, 04:18 PM |
Q3 2022 |
10 |
$325M |
+$13.4M |
-$18M |
-$4.57M |
THC, BRSP, CSTM, PARR, CZR
|
13F-HR |
11/14/2022, 04:38 PM |
Q2 2022 |
11 |
$392M |
+$44.1M |
-$34.5M |
+$9.59M |
THC, BRSP, CSTM, CZR, ATUS
|
13F-HR |
8/15/2022, 05:07 PM |
Q1 2022 |
11 |
$523M |
+$90M |
-$31.5M |
+$58.5M |
THC, BRSP, CSTM, CZR, ATUS
|
13F-HR |
5/16/2022, 04:02 PM |
Q4 2021 |
11 |
$517M |
+$92.3M |
-$84.5M |
+$7.79M |
THC, BRSP, CSTM, STAR, ATUS
|
13F-HR |
2/14/2022, 05:10 PM |
Q3 2021 |
11 |
$470M |
+$36.2M |
-$33.5M |
+$2.71M |
THC, BRSP, CSTM, STAR, PCG
|
13F-HR |
11/15/2021, 05:00 PM |
Q2 2021 |
10 |
$483M |
+$116M |
-$167M |
-$51.6M |
THC, BRSP, CSTM, PCG, PARR
|
13F-HR |
8/13/2021, 04:50 PM |
Q1 2021 |
12 |
$480M |
+$33.6M |
-$81.4M |
-$47.7M |
EPR, THC, PCG, CLNC, CSTM
|
13F-HR |
5/14/2021, 04:16 PM |
Q4 2020 |
11 |
$448M |
+$44.6M |
-$58M |
-$13.3M |
EPR, PCG, THC, CSTM, CLNC
|
13F-HR |
2/16/2021, 05:02 PM |
Q3 2020 |
13 |
$330M |
+$79.9M |
-$98.3M |
-$18.4M |
EPR, PCG, THC, LAUR, CSTM
|
13F-HR |
11/13/2020, 05:07 PM |
Q2 2020 |
14 |
$317M |
+$73.2M |
-$31.9M |
+$41.3M |
EPR, NGHC, CSTM, THC, CLNC
|
13F-HR |
8/13/2020, 05:40 PM |
Q1 2020 |
18 |
$223M |
+$119M |
-$13.5M |
+$106M |
EPR, NGHC, THC, CSTM, HCA
|
13F-HR |
5/14/2020, 04:33 PM |
Q4 2019 |
11 |
$220M |
+$60.7M |
-$57.3M |
+$3.38M |
THC, CSTM, HRI, PCG, NGHC
|
13F-HR |
2/14/2020, 04:49 PM |
Q3 2019 |
12 |
$194M |
+$25.3M |
-$193K |
+$25.1M |
CSTM, HRI, NGHC, LAUR, THC
|
13F-HR |
11/14/2019, 04:15 PM |
Q2 2019 |
11 |
$184M |
+$34.1M |
-$638K |
+$33.5M |
PCG, CSTM, HRI, NGHC, LAUR
|
13F-HR |
8/14/2019, 04:44 PM |
Q1 2019 |
10 |
$130M |
+$54.2M |
-$12M |
+$42.2M |
PCG, HRI, CSTM, NGHC, LAUR
|
13F-HR |
5/14/2019, 04:43 PM |
Q4 2018 |
9 |
$84.4M |
$0 |
$0 |
|
NGHC, CSTM, LAUR, PCG, HRI
|
13F-HR |
2/14/2019, 04:28 PM |